← Open Payments lookup

NPI 1154001675: Open Payments

NPI 1154001675. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$196 in 12 payments from 8 companies in 2025. Trend: 2023 $119 · 2024 $498 · 2025 $196

Food & beverage: $196
CompanyPaymentsAmount
Novo Nordisk Inc3$45
Bayer Healthcare Pharmaceuticals Inc.2$37
Exact Sciences Corporation2$35
ABBVIE INC.1$20
Dexcom, Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15
Lilly USA, LLC1$14
Amgen Inc.1$14

Products named: Kerendia, Ozempic, VRAYLAR, Cologuard Collection Kit, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, XIFAXAN, Rybelsus.